Skip to main content
Voyager Acquisition Corp./Cayman Islands logo

Voyager Acquisition Corp./Cayman Islands — Investor Relations & Filings

Ticker · VACH US Financial and insurance activities
Open in API
Filings indexed 76 across all filing types
Latest filing 2026-05-29 Capital/Financing Update
Country US United States of America
Listing US VACH

About Voyager Acquisition Corp./Cayman Islands

https://www.voyageracq.com/

Voyager Acquisition Corp. is a special purpose acquisition company (SPAC), also known as a blank check company, formed to effect a merger, share exchange, asset acquisition, or similar business combination. The company focuses on acquiring businesses in the healthcare or healthcare-related industries. Following its $253 million initial public offering, Voyager leverages its management team's deep medical expertise, proprietary deal flow, and transaction experience to identify and partner with high-potential companies. The company has entered into a definitive business combination agreement with VERAXA, a biopharmaceutical company, to advance a pipeline of next-generation cancer therapies.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 92% confidence The document is a Form 8-K “Current Report” under Item 1.01 describing entry into multiple securities purchase agreements, private placement of senior secured notes and warrants, and related financing arrangements (including the Lincoln Park purchase agreement). This is a capital/financing update disclosing fundraising activity rather than a full annual or interim report or purely regulatory attestation. Therefore it falls under Capital/Financing Update (CAP).
2026-05-29 English
10-Q
Interim / Quarterly Report
2026-05-20 English
8-K - VOYAGER ACQUISITION CORP./CAYMAN ISLANDS (0002006815) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text references a business combination (merger) between VERAXA Biotech AG and Voyager Acquisition Corp., a SPAC. It includes details about the merger approval, issuance of new shares, and forward-looking statements related to the transaction. The document also references a proxy statement and registration statement related to the business combination. The presence of a Form 8-K and the focus on merger announcement and related disclosures indicate this is a regulatory filing announcing a merger transaction but not the merger proxy statement itself or a full merger filing like DEFM14A. The document is not a full annual or quarterly report, earnings release, or other financial report. It is a current report announcing a material event related to a merger. Therefore, the best classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like M&A filings (which are typically DEFM14A, SC TO, etc.) or proxy solicitation materials (PSI).
2026-02-27 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-13 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or material definitive agreements. The text specifically details an amendment to a Business Combination Agreement and a Sponsor Support Agreement, both related to a merger transaction. It includes forward-looking statements and references to proxy statements and registration statements to be filed later. The document is not a full financial report, earnings release, or proxy solicitation itself, but rather a current report announcing material agreements and updates related to a merger. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like M&A filings (which are typically Forms 425, DEFM14A, etc.) or proxy solicitations. The document length (15,000 characters) and content confirm it is a substantive filing, not just a report publication announcement or certification.
2026-02-03 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.